Close

Regulatory Activity

CMS Finalizes Medicaid DSH Regulations Regarding Treatment of Medicare and Commercial Payments for the Dual Eligibles

The Centers for Medicare & Medicaid Services (CMS) finalized regulations requiring states to include Medicare or commercial payments for services provided to dually eligible Medicaid patients when calculating the hospital-specific limit on DSH payments during annual DSH audits. For some […]

Read More »

HRSA Delays Rule on Determination of 340B Ceiling Prices and Manufacturer Penalties for Overcharging Providers

HRSA furthered delayed implementation of a final rule codifying the calculation of the 340B ceiling price, and implementing civil monetary penalties for manufacturers that knowingly and intentionally overcharge 340B providers.  The final rule had been published on January 5th under […]

Read More »

CMS Posts Changes to Waiver Budget Neutrality Policy

CMS has posted on its website a presentation from May 2016 announcing significant changes to its budget neutrality policy for Section 1115 demonstrations.  The policy could restrict states’ abilities to continue or newly implement Medicaid provider payment programs or other innovations.  Eyman Associates will […]

Read More »

HRSA Opts to Delay 340B Ceiling Price and Manufacturer Overcharging Penalty Rules until October 1, 2017

HRSA issued a rule further delaying until October 1, 2017, the implementation of a January 5th final rule codifying the calculation of the 340B ceiling price, and implementing civil monetary penalties for manufacturers that knowingly and intentionally overcharge 340B providers. A […]

Read More »